High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis
The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Do women with polycystic ovary syndrome (PCOS) have an increased prevalence of moderate and severe depressive and anxiety symptoms compared with control women, and do these symptoms correlate with age, BMI, testosterone, hirsutism or insulin resistance (IR)? SUMMARY ANSWER: Women with PCOS have significantly increased odds of moderate and severe depressive and anxiety symptoms, independent of obesity, and the symptoms are weakly associated with age, BMI, elevated testosterone, hirsutism and IR. WHAT IS KNOWN ALREADY: Previous studies have reported that women with PCOS have an increased prevalence of mild depressive and anxiety symptoms or an increase in mean depression and anxiety scores, although these scores are usually within the normal range. Thus, it is therefore not clear whether these findings are clinically significant. The prevalence of moderate and severe depressive and anxiety symptoms, which require follow-up and would benefit from treatment, is not known in this population. STUDY DESIGN, SIZE, DURATION: A comprehensive systematic review (SR) was performed up to January 2016 and included 30 cross-sectional studies, representing 3050 subjects with PCOS and 3858 controls, from 10 different countries. The meta-analysis (MA) on depressive symptoms included 18 studies and the MA on anxiety symptoms included 9 studies. A separate SR identified 15 studies for the meta-regression examining the associations with PCOS-related symptoms or comorbidities. PARTICIPANTS/MATERIALS, SETTING, METHODS: All studies included adult women with PCOS, defined by the National Institutes of Health or Rotterdam criteria, and a control group without PCOS. Ovid, Embase, PsychInfo and Cochrane were searched up to January 2016. Included studies used a validated screening tool to compare the prevalence or mean scores of depressive and/or anxiety symptoms. Random effects MA was used to estimate the pooled odds ratio (OR) of depressive and anxiety symptoms. Sensitivity analyses of methodological characteristics and a meta-regression of the pooled standardized mean difference (SMD) to evaluate PCOS-related clinical and laboratory associations were performed. MAIN RESULTS AND THE ROLE OF CHANCE: Women with PCOS had increased odds of any depressive symptoms (OR: 3.78; 95% CI: 3.03-4.72; 18 studies) and of moderate/severe depressive symptoms (OR: 4.18; 95% CI: 2.68-6.52; 11 studies). Women with PCOS had increased odds of any anxiety symptoms (OR: 5.62; 95% CI: 3.22-9.80, nine studies) and of moderate/severe anxiety symptoms (OR: 6.55; 95% CI: 2.87, 14.93; five studies). When subjects were matched on BMI, women with PCOS still had higher odds of both depressive (OR: 3.25; 95% CI 1.73-6.09; four studies) and anxiety symptoms (OR: 6.30, 95% CI: 1.88-21.09; three studies). There was no substantial heterogeneity among studies in the overall MA on depressive symptoms (I2 = 22.4%, P = 0.19), but there was significant heterogeneity among studies in the analysis on anxiety symptoms (I2 = 59.6%, P= 0.01). In the meta-regression evaluating pooled SMDs between groups, women with PCOS and concurrent depression had higher mean values of age, BMI, hirsutism score and IR, while women with PCOS and concurrent anxiety had higher mean values of BMI, hirsutism score and free testosterone (P < 0.05 for all comparisons). LIMITATIONS, REASON FOR CAUTION: All studies were cross-sectional, thus we can only hypothesize that the diagnosis of PCOS precedes the diagnosis of depression and anxiety. There were large variations in methodological characteristics especially in the studies screening for anxiety; however, they only partly explained effect size variation. WIDER IMPLICATIONS OF THE FINDINGS: This evidence-synthesis analysis shows that PCOS diagnosis is associated with an increased risk of moderate and severe depressive and anxiety symptoms and suggests that providers should consider screening women with PCOS for both depression and anxiety. Although age, obesity, hyperandrogenism and IR do not explain the entire association, well-designed studies are needed to assess the impact of treatment of these factors on depressive and anxiety symptoms in women with PCOS. STUDY FUNDING/COMPETING INTEREST(S): No funding was used for this study. There are no conflicts of interest. REGISTRATION NUMBER: N/A.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is concerning given the established evidence of increased depression, anxiety, eating disorders and other mental illnesses in those affected with PCOS [3, 8, 57–59].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [58]
In the citing paper
“This prevalence of eating disorders is relatively high compared to that found in other population studies that report a 0.3%-2.45% prevalence in those with PCOS.31,126,129,130”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [129]
In the citing paper
“Another meta-analysis estimated a prevalence of 36 % for depression in PCOS [69].”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [69]
In the citing paper
“The risk of developing depression may be associated with higher BMI [70], although this association is weak.”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [70]
In the citing paper
“A recent meta-analysis of depression rates among women with PCOS resulted in a median prevalence of depression of almost 37% compared to 14% in controls [8].”
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement
Siu, A. L., and the US Preventive Services Task Force (USPSTF), Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., García, F. A. R., Gillman, M., Herzstein, J., et al. (2016) · JAMA · doi:10.1001/jama.2015.18392 · Cited by 1,407
Research works printed but not linked: 3
- 2014, Body image, self-esteem and depressive symptomatology in women with polycystic ovary syndrome, Noropsikiyatri Arsivi, 51, 129
- 2013, Psychiatric symptoms in women with polycystic ovary syndrome, Dusunen Adam, 26, 157
- 1992, Polycystic ovary syndrome, 377
Cited by
Day, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007813 · Cited by 619
Update on PCOS: consequences, challenges, and guiding treatment
Hoeger, K. M., Dokras, A., & Piltonen, T. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa839 · Cited by 610
Self-citationComorbid depression in medical diseases
Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 534
Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome
Stener-Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa010 · Cited by 348
Adolescent polycystic ovary syndrome according to the international evidence-based guideline
Peña, A. S., Witchel, S. F., Hoeger, K. M., Oberfield, S. E., Vogiatzi, M. G., Misso, M., Garad, R., Dabadghao, P., & Teede, H. (2020) · BMC Medicine · doi:10.1186/s12916-020-01516-x · Cited by 301
Dokras, A., Stener-Victorin, E., Yildiz, B. O., Li, R., Ottey, S., Shah, D., Epperson, N., & Teede, H. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.01.038 · Cited by 285
Self-citationBeyond fertility: polycystic ovary syndrome and long-term health
Cooney, L. G., & Dokras, A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.021 · Cited by 270
Self-citationHormonal Treatments for Major Depressive Disorder: State of the Art
Dwyer, J. B., Aftab, A., Radhakrishnan, R., Widge, A., Rodriguez, C. I., Carpenter, L. L., Nemeroff, C. B., McDonald, W. M., Kalin, N. H., & APA Council of Research Task Force on Novel Biomarkers and Treatments (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.19080848 · Cited by 252
Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis
Brutocao, C., Zaiem, F., Alsawas, M., Morrow, A. S., Murad, M. H., & Javed, A. (2018) · Endocrine · doi:10.1007/s12020-018-1692-3 · Cited by 251
Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity
Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01208-y · Cited by 240
Neven, A., Laven, J., Teede, H., & Boyle, J. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1668085 · Cited by 196
Anxiety, Depression, and Quality of Life in Women with Polycystic Ovarian Syndrome
Chaudhari, A. P., Mazumdar, K., & Mehta, P. D. (2018) · Indian Journal of Psychological Medicine · doi:10.4103/ijpsym.ijpsym_561_17 · Cited by 187
Polycystic ovary syndrome throughout a woman’s life
Group of interest in Reproductive Endocrinology (GIER) of the Spanish Fertility Society (SEF), Bellver, J., Rodríguez-Tabernero, L., Robles, A., Muñoz, E., Martínez, F., Landeras, J., García-Velasco, J., Fontes, J., Álvarez, M., et al. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-1047-7 · Cited by 180
Characteristics of polycystic ovary syndrome throughout life
Louwers, Y. V., & Laven, J. S. E. (2020) · Therapeutic Advances in Reproductive Health · doi:10.1177/2633494120911038 · Cited by 174
Ostadmohammadi, V., Jamilian, M., Bahmani, F., & Asemi, Z. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0480-x · Cited by 169
Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment
Cooney, L. G., & Dokras, A. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0834-2 · Cited by 165
Self-citationTan, W., Dai, F., Yang, D., Deng, Z., Gu, R., Zhao, X., & Cheng, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967151 · Cited by 163
Alur-Gupta, S., Chemerinski, A., Liu, C., Lipson, J., Allison, K., Sammel, M. D., & Dokras, A. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.06.018 · Cited by 161
Self-citationWitchel, S. F., Teede, H. J., & Peña, A. S. (2019) · Pediatric Research · doi:10.1038/s41390-019-0615-1 · Cited by 156
Hiam, D., Moreno‐Asso, A., Teede, H. J., Laven, J. S. E., Stepto, N. K., Moran, L., & Gibson‐Helm, M. E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101606 · Cited by 151
Silva, M. S. B., & Giacobini, P. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03576-x · Cited by 149
PCOS and Depression: Common Links and Potential Targets
Kolhe, J. V., Chhipa, A. S., Butani, S., Chavda, V. K., & Patel, S. S. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00765-2 · Cited by 139
Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review
Livadas, S., Anagnostis, P. G., Bosdou, J. Κ., Bantouna, D., & Paparodis, R. D. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i1.5 · Cited by 130
Measures of health-related quality of life in PCOS women: a systematic review
Behboodi Moghadam, Z., Fereidooni, B., Saffari, M., & Montazeri, A. (2018) · International Journal of Women's Health · doi:10.2147/ijwh.s165794 · Cited by 129
Kogure, G. S., Ribeiro, V. B., Lopes, I. P., Furtado, C. L. M., Kodato, S., de Sá, M. F. S., Ferriani, R. A., Lara, L. A. D. S., & dos Reis, R. M. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.05.006 · Cited by 121
Cooney, L. G., Milman, L. W., Hantsoo, L., Kornfield, S., Sammel, M. D., Allison, K. C., Epperson, C. N., & Dokras, A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.03.028 · Cited by 117
Self-citationPolycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes
Berni, T. R., Morgan, C. L., Berni, E. R., & Rees, D. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02667 · Cited by 111
Zhu, S., Zhang, B., Jiang, X., Li, Z., Zhao, S., Cui, L., & Chen, Z.-J. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.09.013 · Cited by 109
Klügel, S., Lücke, C., Meta, A., Schild-Suhren, M., Malik, E., Philipsen, A., & Müller, H. (2017) · International Journal of Women s Health · doi:10.2147/ijwh.s143368 · Cited by 105
Emanuel, R. H. K., Roberts, J., Docherty, P. D., Lunt, H., Campbell, R. E., & Möller, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1017468 · Cited by 100
Anxiety and Depression in Women with Polycystic Ovary Syndrome
Dybciak, P., Humeniuk, E., Raczkiewicz, D., Krakowiak, J., Wdowiak, A., & Bojar, I. (2022) · Medicina · doi:10.3390/medicina58070942 · Cited by 99
Papadakis, G. E., Kandaraki, E., Tseniklidi, E., Papalou, O., & Diamanti‐Kandarakis, E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00388 · Cited by 95
Differential Expression Profile of Plasma Exosomal MicroRNAs in Women with Polycystic Ovary Syndrome
Jiang, X., Li, J., Zhang, B., Hu, J., Ma, J., Cui, L., & Chen, Z.-J. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.08.019 · Cited by 93
Psychiatric disorders in women with polycystic ovary syndrome
Rodriguez-Paris, D., Remlinger-Molenda, A., Kurzawa, R., Głowińska, A., Spaczyński, R., Rybakowski, F., Pawelczyk, L. A., & Banaszewska, B. (2019) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/93105 · Cited by 93
Lee, I., Cooney, L. G., Saini, S., Sammel, M. D., Allison, K. C., & Dokras, A. (2019) · Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity · doi:10.1007/s40519-018-0533-y · Cited by 92
Self-citationPolycystic ovarian syndrome–related depression in adolescent girls: A Review
Sadeeqa, S., Mustafa, T., & Latif, S. (2018) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_1_18 · Cited by 92
PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment
Męczekalski, B., Niwczyk, O., Kostrzak, A., Maciejewska-Jeske, M., Bala, G., & Szeliga, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031221 · Cited by 92
Depression in polycystic ovary syndrome: Focusing on pathogenesis and treatment
Xing, L., Xu, J., Wei, Y., Chen, Y., Zhuang, H., Tang, W., Yu, S., Zhang, J., Yin, G., Wang, R., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1001484 · Cited by 91
Wang, Y., Ni, Z., & Li, K. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1942452 · Cited by 90
Coyle, C., & Campbell, R. E. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110561 · Cited by 89
Insulin Resistance is Associated with Depression Risk in Polycystic Ovary Syndrome
Greenwood, E. A., Pasch, L. A., Cedars, M. I., Legro, R. S., Eisenberg, E., & Huddleston, H. G. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.03.009 · Cited by 88
Phylactou, M., Clarke, S. A., Patel, B., Baggaley, C., Jayasena, C. N., Kelsey, T., Comninos, A. N., Dhillo, W. S., & Abbara, A. (2020) · Clinical Endocrinology · doi:10.1111/cen.14402 · Cited by 87
Forslund, M., Melin, J. M., Alesi, S., Piltonen, T., Romualdi, D., Tay, C. T., Witchel, S. F., Peña, A. S., Mousa, A., & Teede, H. J. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad082 · Cited by 85
Depression in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Dybciak, P., Raczkiewicz, D., Humeniuk, E., Powrózek, T., Gujski, M., Malecka-Massalska, T. J., Wdowiak, A., & Bojar, I. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206446 · Cited by 83
Long‐term health outcomes in young women with polycystic ovary syndrome: A narrative review
Allen, L. A., Shrikrishnapalasuriyar, N., & Rees, A. (2021) · Clinical Endocrinology · doi:10.1111/cen.14609 · Cited by 80
Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome
Joham, A. E., Piltonen, T., Lujan, M. E., Kiconco, S., & Tay, C. T. (2022) · Clinical Endocrinology · doi:10.1111/cen.14757 · Cited by 80
Neubronner, S., Indran, I. R., Chan, Y. H., Thu, W. P. P., & Yong, E. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01277-6 · Cited by 79
Association among depression, symptom experience, and quality of life in polycystic ovary syndrome
Greenwood, E. A., Pasch, L. A., Cedars, M. I., Legro, R. S., & Huddleston, H. G. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.06.017 · Cited by 78
An Update on Contraception in Polycystic Ovary Syndrome
Oguz, S. H., & Yildiz, B. O. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.958 · Cited by 76
Jiskoot, G., Dietz de Loos, A., Beerthuizen, A., Timman, R., Busschbach, J., & Laven, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233876 · Cited by 76
Pundir, J., Charles, D., Sabatini, L., Hiam, D., Jitpiriyaroj, S., Teede, H. J., Coomarasamy, A., Moran, L., & Thangaratinam, S. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy045 · Cited by 76
Copp, T., Hersch, J. K., Muscat, D. M., McCaffery, K. J., Doust, J. A., Dokras, A., Mol, B. W., & Jansen, J. (2019) · Human Reproduction Open · doi:10.1093/hropen/hoz026 · Cited by 73
Self-citationPolycystic Ovary Syndrome in Adolescence
Deans, R. (2019) · Medical Sciences · doi:10.3390/medsci7100101 · Cited by 72
Kallak, T. K., Hellgren, C., Skalkidou, A., Sandelin-Francke, L., Ubhayasekhera, K., Bergquist, J., Axelsson, O., Comasco, E., Campbell, R. E., & Sundström Poromaa, I. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0207 · Cited by 70
Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success
Ee, C., Pirotta, S., Mousa, A., Moran, L., & Lim, S. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00890-8 · Cited by 70
Exercise and insulin resistance in PCOS: muscle insulin signalling and fibrosis
Stepto, N. K., Hiam, D., Gibson‐Helm, M. E., Cassar, S., Harrison, C. L., Hutchison, S. K., Joham, A. E., Canny, B. J., Moreno‐Asso, A., Strauss, B. J., et al. (2020) · Endocrine Connections · doi:10.1530/ec-19-0551 · Cited by 69
Ismayilova, M., & Yaya, S. (2022) · BMC Women's Health · doi:10.1186/s12905-022-01630-3 · Cited by 68
“Several guidelines have been published in the last 5–10 years detailing the need for mental health screening at the time of diagnosis [13, 15, 17].”
BackgroundRisal, S., Manti, M., Lu, H., Fornes, R., Larsson, H., Benrick, A., Deng, Q., Cesta, C. E., Rosenqvist, M. A., & Stener‐Victorin, E. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01183-9 · Cited by 66
Patten, R. K., McIlvenna, L. C., Moreno‐Asso, A., Hiam, D., Stepto, N. K., Rosenbaum, S., & Parker, A. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-29503-1 · Cited by 66
Sabag, A., Patten, R. K., Moreno‐Asso, A., Colombo, G. E., Bouzo, X. D., Moran, L., Harrison, C. L., Kazemi, M., Mousa, A., Tay, C. T., et al. (2024) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2024.05.015 · Cited by 66
Greenwood, E. A., Yaffe, K. S., Wellons, M., Cedars, M. I., & Huddleston, H. G. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00234 · Cited by 66
Xi, D., Chen, B., Tao, H., Xu, Y., & Chen, G. (2023) · Archives of Women s Mental Health · doi:10.1007/s00737-022-01289-7 · Cited by 65
Mukherjee, A. G., Wanjari, U. R., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Dey, A., Babu, A., Renu, K., Vellingiri, B., et al. (2023) · Metabolites · doi:10.3390/metabo13010129 · Cited by 64
Prevalence and Etiology of Eating Disorders in Polycystic Ovary Syndrome: A Scoping Review
Lalonde-Bester, S., Malik, M., Masoumi, R., Ng, K., Sidhu, S., Ghosh, M., & Vine, D. F. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100193 · Cited by 63
Alur-Gupta, S., Dokras, A., & Cooney, L. G. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.01.018 · Cited by 62
Self-citationSydora, B. C., Wilke, M. S., McPherson, M., Chambers, S., Ghosh, M., & Vine, D. F. (2023) · BMC Women's Health · doi:10.1186/s12905-023-02732-2 · Cited by 60
“Thus, routine screening for mental illnesses including anxiety, depression and eating disorders at the time of PCOS diagnosis or during follow-up care and referral to psychiatric counselling is recommended for those with PCOS [3, 8, 57, 58].”
BackgroundComplex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus
Rodgers, R. J., Avery, J. C., Moore, V. M., Davies, M. J., Azziz, R., Stener-Victorin, E., Moran, L. J., Robertson, S. A., Stepto, N. K., Norman, R. J., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0502 · Cited by 60
Sánchez-Ferrer, M. L., Adoamnei, E., Prieto‐Sánchez, M. T., Mendiola, J., Corbalán‐Biyang, S., Moñino-García, M., Palomar-Rodríguez, J.-A., & Torres-Cantero, A. M. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01484-z · Cited by 59
Piltonen, T. T., Ruokojärvi, M., Karro, H., Kujanpää, L., Morin-Papunen, L., Tapanainen, J. S., Stener-Victorin, E., Sundrström-Poromaa, I., Hirschberg, A. L., Ravn, P., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0226074 · Cited by 58
Pirotta, S., Joham, A. E., Moran, L., Skouteris, H., & Lim, S. S. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2021.01.036 · Cited by 57
Gibson-Helm, M., Dokras, A., Karro, H., Piltonen, T., & Teede, H. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667155 · Cited by 56
Self-citationCardiometabolic Risk in Polycystic Ovary Syndrome
Cooney, L. G., & Dokras, A. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.11.001 · Cited by 56
Self-citationPolycystic ovary syndrome and aging: Health implications after menopause
Helvacı, N., & Yıldız, B. O. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.05.013 · Cited by 55
Quality of life and sexual function in women with polycystic ovary syndrome: a comprehensive review
Castelo‐Branco, C., & Naumova, I. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1670788 · Cited by 54
Vine, D., Ghosh, M., Wang, T., & Bakal, J. (2024) · CJC Open · doi:10.1016/j.cjco.2023.12.010 · Cited by 53
“7,29,32,127,128 Eating disorders can be a product of depression and anxiety in the PCOS patient, and we have shown that eating disorders have a 5.7% prevalence in those with PCOS, and a 40% higher prevalence, as compared to non-PCOS controls.”
ResultInfluentialPostpartum complications increased in women with polycystic ovary syndrome
Alur-Gupta, S., Boland, M. R., Barnhart, K. T., Sammel, M. D., & Dokras, A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.048 · Cited by 53
Self-citationPsychological burden among women with polycystic ovarian syndrome in Oman: a case–control study
Sulaiman, M., Al-Farsi, Y. M., Al‐Khaduri, M., Waly, M. I., Saleh, J., & Al‐Adawi, S. (2017) · International Journal of Women s Health · doi:10.2147/ijwh.s145383 · Cited by 53
Che, Q., Liu, M., Xu, J., Liu, Y., Cao, X., Dong, X., & Liu, S. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.02.023 · Cited by 53
Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome?
Copp, T., Jansen, J., Doust, J. A., Mol, B. W., Dokras, A., & McCaffery, K. J. (2017) · BMJ · doi:10.1136/bmj.j3694 · Cited by 52
Self-citationSong, Y., Ye, W., Ye, H., Xie, T., Shen, W., & Zhou, L. (2019) · Physiological Reports · doi:10.14814/phy2.14219 · Cited by 52
Krug, I., Giles, S., & Paganini, C. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s168944 · Cited by 50
Alzueta, E., & Baker, F. C. (2023) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2023.06.003 · Cited by 50
Karjula, S., Morin-Papunen, L., Franks, S., Auvinen, J., Järvelin, M.-R., Tapanainen, J. S., Jokelainen, J., Miettunen, J., & Piltonen, T. T. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz256 · Cited by 49
Manti, M., Fornes, R., Qi, X., Folmerz, E., Hirschberg, A. L., Barbosa, T. D. C., Maliqueo, M. A., Benrick, A., & Stener‐Victorin, E. (2018) · The FASEB Journal · doi:10.1096/fj.201701263rr · Cited by 49
Tassone, E., Teede, H., Dokras, A., Garad, R., & Gibson-Helm, M. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1668086 · Cited by 48
Self-citationLin, H., Liu, M., Zhong, D., Ng, E. H. Y., Liu, J., Li, J., Shi, Y., Zhang, C., Wen, X., Mai, Z., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.709674 · Cited by 47
Update on Animal Models of Polycystic Ovary Syndrome
Stener‐Victorin, E. (2022) · Endocrinology · doi:10.1210/endocr/bqac164 · Cited by 46
The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
Sivanandy, M. S., & Ha, S. K. (2023) · Diagnostics · doi:10.3390/diagnostics13050907 · Cited by 46
Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis
Pastoor, H., Mousa, A., Hanneke, B., Bramer, W. M., Burgert, T. S., Dokras, A., Tay, C. T., Teede, H. J., & Laven, J. S. E. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmad034 · Cited by 46
Self-citationAnxiety, depression, and body image among infertile women with and without polycystic ovary syndrome
Jannink, T. I., Bordewijk, E. M., Aalberts, J. L., Hendriks, J., Lehmann, V., Hoek, A., Goddijn, M., van Wely, M., ANDES study group, de Bruin, J. P., et al. (2024) · Human Reproduction · doi:10.1093/humrep/deae016 · Cited by 46
Anxiety and depression states of adolescents with polycystic ovary syndrome
Emeksiz, H. C., Bıdecı, A., Nalbantoğlu, B., Nalbantoğlu, A., ÇELİK, C., Yulaf, Y., Çamurdan, M. O., & Cınaz, P. (2018) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1708-131 · Cited by 46
Knowledge of PCOS in physicians-in-training: identifying gaps and educational opportunities
Chemerinski, A., Cooney, L., Shah, D., Butts, S., Gibson-Helm, M., & Dokras, A. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1746761 · Cited by 45
Self-citationHasan, M., Sultana, S., Sohan, M., Parvin, S., Rahman, M. A., Hossain, M. J., Rahman, M. S., & Islam, M. R. (2022) · PLOS ONE · doi:10.1371/journal.pone.0270102 · Cited by 45
Wang, G., Liu, X., Zhu, S., & Lei, J. (2023) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2023.2218987 · Cited by 45
Cooney, L. G., Gyorfi, K. M., Sanneh, A., Bui, L. M., Mousa, A., Tay, C. T., Teede, H. J., Stener‐Victorin, E., & Brennan, L. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae462 · Cited by 45
Self-citationBurnatowska, E., Wikarek, A., Oboza, P., Ogarek, N., Glinianowicz, M., Kocelak, P., & Olszanecka-Glinianowicz, M. (2023) · Nutrients · doi:10.3390/nu15020295 · Cited by 44
“The factors associated with the increased prevalence of depression and anxiety were advanced age, higher BMI value, and hirsutism score [59].”
BackgroundLi, Y., Zhang, J., Zheng, X., Lu, W., Guo, J., Chen, F., & Liu, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1399580 · Cited by 44
Alur-Gupta, S., Lee, I. T., Chemerinski, A., Liu, C., Lipson, J., Allison, K. C., Gallop, R., & Dokras, A. (2021) · F&S Reports · doi:10.1016/j.xfre.2021.03.003 · Cited by 44
Self-citationSpritzer, P. M., Marchesan, L. B., dos Santos, B. R., Cureau, F. V., Oppermann, K., dos Reis, R. M., Ferriani, R. A., Weiss, R. V., Meirelles, R. M. R., Cândido, A. L., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029191 · Cited by 43
Depressive and Anxiety Symptom Assessment in Adults with Polycystic Ovarian Syndrome
Almeshari, W. K., Alsubaie, A. K., Alanazi, R. I., Almalki, Y., Masud, N., & Mahmoud, S. H. (2021) · Depression Research and Treatment · doi:10.1155/2021/6652133 · Cited by 43
Metadata
- Authors
- Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A.
- Affiliations
- Hospital of the University of Pennsylvania (US)
- Corresponding author
- Cooney, Laura G.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-09
- Volume
- 32
- Issue
- 5
- Pages
- 1075-1091
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2592269563
- Cited by
- 631
- References
- 80
- Citations by year
- 2026: 95 · 2025: 94 · 2024: 63 · 2023: 81 · 2022: 70 · 2021: 77 · 2020: 56 · 2019: 49 · 2018: 35 · 2017: 10
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- polycystic ovary syndrome, depressive symptoms, anxiety symptoms, depression prevalence, anxiety prevalence, obesity, insulin resistance, testosterone, hirsutism, body mass index, age, women's mental health, comorbidities, Rotterdam criteria, NIH criteria, screening tool, meta-regression, standardized mean difference
- MeSH terms
- Anxiety, Depression, Female, Humans, Polycystic Ovary Syndrome, Severity of Illness Index, Comorbidity, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.